SCHEMBL847378

SCHEMBL847378

CCCCC(CCCCBr)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 7/20 0.63
MAPK1 P28482 1/20 0.63
CHRM1 P11229 1/20 0.54
AKR1A1 P14550 1/20 0.54
CHRM3 P20309 1/20 0.54
HTR2A P28223 1/20 0.54
HTR2C P28335 1/20 0.54
ADRA1A P35348 1/20 0.54
HRH1 P35367 1/20 0.54
DRD3 P35462 1/20 0.54
SLC6A3 Q01959 1/20 0.54
HDAC1 Q13547 1/20 0.54
HDAC2 Q92769 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
SLC1A2 P43004 2/20 0.53
SLC1A1 P43005 2/20 0.53
SLC1A3 P43003 1/20 0.53
GRIK1 P39086 2/20 0.52
GRIK2 Q13002 2/20 0.52
LCK P06239 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27141501 0.96 CA2 (0.57) CA2MAPK1CHRM1AKR1A1CHRM3
SCHEMBL29148318 0.94 GRIK1 (0.58) CA2MAPK1CHRM1AKR1A1CHRM3
SCHEMBL29113655 0.94 GRIK1 (0.58) CA2MAPK1CHRM1AKR1A1CHRM3
SCHEMBL29272712 0.94 GRIK1 (0.58) CA2MAPK1CHRM1AKR1A1CHRM3
SCHEMBL18641746 0.94 GRIK1 (0.58) CA2MAPK1CHRM1AKR1A1CHRM3
SCHEMBL29065685 0.94 GRIK1 (0.58) CA2MAPK1CHRM1AKR1A1CHRM3
SCHEMBL29099719 0.94 GRIK1 (0.58) CA2MAPK1CHRM1AKR1A1CHRM3
SCHEMBL29113621 0.94 GRIK1 (0.58) CA2MAPK1CHRM1AKR1A1CHRM3
SCHEMBL29024152 0.94 GRIK1 (0.58) CA2MAPK1CHRM1AKR1A1CHRM3
SCHEMBL29024122 0.94 GRIK1 (0.58) CA2MAPK1CHRM1AKR1A1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2432318-A1 BIMACROCYCLIC HCV NS3 PROTEASE INHIBITORS Sequoia Pharmaceuticals, Inc. (US) 2012-03-28 EP disclosed
WO-2010135748-A1 BIMACROCYCLIC HCV NS3 PROTEASE INHIBITORS SEQUOIA PHARMACEUTICALS INC. (US) 2010-11-25 WO disclosed
US-5075043-A Liquid crystals EASTMAN KODAK COMPANY (US) 1991-12-24 US disclosed
EP-0370922-A2 An optical article containing a linear condensation polymer exhibiting a high level of second order polarization susceptibility EASTMAN KODAK COMPANY (US) 1990-05-30 EP disclosed